FdaApplication

ANDA 207167

Back to search

Identifiers

Properties

PropertyValue
applicant_nameAUROBINDO PHARMA LTD
application_typeANDA
approval_date2023-03-28

Products (2)

ProductActive ingredientStrengthDosage form
LANSOPRAZOLELANSOPRAZOLE30MGTABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL
LANSOPRAZOLELANSOPRAZOLE15MGTABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL

2 products